Advisor Group Holdings, Inc. Belite Bio, Inc Call Options Transaction History
Advisor Group Holdings, Inc.
- $52.6 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BLTE
# of Institutions
19Shares Held
79.9KCall Options Held
0Put Options Held
0-
State Street Corp Boston, MA20.2KShares$2.28 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA12.9KShares$1.45 Million0.0% of portfolio
-
Marshall Wace, LLP London, X09.49KShares$1.07 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY8.16KShares$920,8360.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il7.46KShares$841,1850.0% of portfolio
About BELITE BIO, INC
- Ticker BLTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,867,400
- Market Cap $2.81B
- Description
- Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery o...